arbekacin






15 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1507428 [Vancomycin and arbekacin, drugs of treatment for MRSA infections]. Nihon Rinsho 1992 May 2
2 8072164 [Special issue: Current state of MRSA infections and practical chemotherapy with arbekacin]. Jpn J Antibiot 1994 Jun 1
3 8072181 [Clinical efficacy of arbekacin on MRSA infections]. Jpn J Antibiot 1994 Jun 2
4 8072185 [Clinical efficacy of arbekacin on MRSA infections with hematopoietic disorders. The Hanshin Study Group of Hematopoietic Disorders and Infections]. Jpn J Antibiot 1994 Jun 3
5 8072194 [Clinical effect of arbekacin on MRSA infections after gastrointestinal surgery]. Jpn J Antibiot 1994 Jun 1
6 10923284 [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)]. Jpn J Antibiot 2000 May 1
7 11295432 Calcium-induced changes in chondroitin sulfate chains of urinary trypsin inhibitor. Biochim Biophys Acta 2001 Apr 7 1
8 11551435 Cloud-point temperatures for lysozyme in electrolyte solutions: effect of salt type, salt concentration and pH. Biophys Chem 2001 Jul 24 1
9 12791416 Arbekacin is actively secreted in the rat intestine via a different efflux system from P-glycoprotein. Eur J Pharm Sci 2003 Jun 2
10 18452409 Evaluation of the clinical application of cystatin C, a new marker of the glomerular filtration rate, for the initial dose-setting of arbekacin. J Clin Pharm Ther 2008 Jun 4
11 23615919 Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans. Psychopharmacology (Berl) 2013 Sep 1
12 25359239 Aminoglycosides suppress the protein folding activity of the molecular chaperone HSC70: implication of a structure-activity relationship. Chemotherapy 2014 2
13 27260679 Population pharmacokinetics of arbekacin in different infectious disease settings and evaluation of dosing regimens. J Infect Chemother 2016 Jul 1
14 29661878 Plasticity of Aminoglycoside Binding to Antibiotic Kinase APH(2″)-Ia. Antimicrob Agents Chemother 2018 Jul 1
15 32661000 Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Dose Selection for ME1100, an Arbekacin Inhalation Solution. Antimicrob Agents Chemother 2020 Sep 21 8